Radiofrequency ablation is a valid treatment option for lung metastases: Experience in 566 patients with 1037 metastases

Annals of Oncology

Volumn 26, Issue 5, 2015, Pages 987-991

  De Baère, Thierry ^a   Auperin A ^a   Deschamps, F ^a   Chevallier, P ^b   Gaubert, Y ^c   Boige, V ^a   Fonck, M ^d   Escudier, B ^a   Palussiere J ^d  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^c TIMONE HOSPITAL   (France)

^d INSTITUT BERGONIÉ   (France)

Author keywords

Colorectal cancer; Lung metastases; Radiofrequency ablation; Thermal ablation

Indexed keywords

ADOLESCENT; AGED; ARTERY PUNCTURE; ARTICLE; ARTIFICIAL EMBOLISM; BONE METASTASIS; BURN; CANCER CONTROL; CANCER PROGNOSIS; CANCER SURVIVAL; CARDIOPULMONARY INSUFFICIENCY; CEREBROVASCULAR ACCIDENT; CLINICAL EFFECTIVENESS; COMPUTER ASSISTED TOMOGRAPHY; DISEASE FREE INTERVAL; FACTUAL DATABASE; FEMALE; FOLLOW UP; HEMATOTHORAX; HUMAN; LENGTH OF STAY; LIVER METASTASIS; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTATIC COLORECTAL CANCER; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATIENT SAFETY; PNEUMOTHORAX; PRIMARY TUMOR; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROSPECTIVE STUDY; RADIOFREQUENCY ABLATION; SURGICAL DRAINAGE; SURVIVAL RATE; SURVIVAL TIME; TREATMENT FAILURE; TUMOR LOCALIZATION; TUMOR VOLUME; WORK EXPERIENCE; ADULT; ADVERSE EFFECTS; CATHETER ABLATION; CLINICAL TRIAL; DIAGNOSTIC IMAGING; DISEASE COURSE; DISEASE FREE SURVIVAL; FRANCE; INTERVENTIONAL RADIOLOGY; LUNG NEOPLASMS; METASTASIS RESECTION; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PATIENT SELECTION; PROCEDURES; RISK FACTOR; SECONDARY; SURVIVAL ANALYSIS; TIME FACTOR; TREATMENT OUTCOME; VERY ELDERLY; X-RAY COMPUTED TOMOGRAPHY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CATHETER ABLATION; DATABASES, FACTUAL; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; FRANCE; HUMANS; LUNG NEOPLASMS; MALE; METASTASECTOMY; MIDDLE AGED; PATIENT SELECTION; RADIOGRAPHY, INTERVENTIONAL; RISK FACTORS; SURVIVAL ANALYSIS; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; TUMOR BURDEN; YOUNG ADULT;

EID: 84929076387     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdv037     Document Type: Article

References (17)

1. Ahmed M, Liu Z, Afzal KS et al. Radiofrequency ablation: effect of surrounding tissue composition on coagulation necrosis in a canine tumor model. Radiology 2004; 230: 761-767.
2. Jaskolka JD, Kachura JR, Hwang DM et al. Pathologic assessment of radiofrequency ablation of pulmonary metastases. J Vasc Interv Radiol 2010; 21: 1689-1696.
3. Dupuy DE, Zagoria RJ, Akerley W et al. Percutaneous radiofrequency ablation of malignancies in the lung. AJR Am J Roentgenol 2000; 174: 57-59.
4. de Baere T, Palussiere J, Auperin A et al. Mid-term local efficacy and survival after radiofrequency ablation of lung tumors with a minimum follow-up of 1 year: prospective evaluation. Radiology 2006; 240: 587-596.
5. Hess A, Palussiere J, Goyers JF et al. Pulmonary radiofrequency ablation in patients with a single lung: feasibility, efficacy, and tolerance. Radiology 2011; 258: 635-642.
6. King J, Glenn D, Clark W et al. Percutaneous radiofrequency ablation of pulmonary metastases in patients with colorectal cancer. Br J Surg 2004; 91: 217-223.
7. Palussiere J, Gomez F, Cannella M et al. Single-session radiofrequency ablation of bilateral lung metastases. Cardiovasc Intervent Radiol 2012; 35: 852-859.
8. Chua TC, Sarkar A, Saxena A et al. Long-term outcome of image-guided percutaneous radiofrequency ablation of lung metastases: an open-labeled prospective trial of 148 patients. Ann Oncol 2010; 21: 2017-2022.
9. Gillams A, Khan Z, Osborn P, Lees W. Survival after radiofrequency ablation in 122 patients with inoperable colorectal lung metastases. Cardiovasc Intervent Radiol 2013; 36: 724-730.
10. Iida T, Nomori H, Shiba M et al. Prognostic factors after pulmonary metastasectomy for colorectal cancer and rationale for determining surgical indications: a retrospective analysis. Ann Surg 2012.
11. Pfannschmidt J, Hoffmann H, Dienemann H. Reported outcome factors for pulmonary resection in metastatic colorectal cancer. J Thorac Oncol 2010; 5: S172-S178.
12. Zheng Y, Fernando HC. Surgical and nonresectional therapies for pulmonary metastasis. Surg Clin North Am 2010; 90: 1041-1051.
13. Landreneau RJ, De Giacomo T, Mack MJ et al. Therapeutic video-assisted thoracoscopic surgical resection of colorectal pulmonary metastases. Eur J Cardiothorac Surg 2000; 18: 671-676; discussion 676-677.
14. Shiono S, Ishii G, Nagai K et al. Predictive factors for local recurrence of resected colorectal lung metastases. Ann Thorac Surg 2005; 80: 1040-1045.
15. Pastorino U, McCormack PM, Ginsberg RJ. A new staging proposal for pulmonary metastases. The results of analysis of 5206 cases of resected pulmonary metastases. Chest Surg Clin N Am 1998; 8: 197-202.
16. Gonzalez M, Poncet A, Combescure C et al. Risk factors for survival after lung metastasectomy in colorectal cancer patients: a systematic review and metaanalysis. Ann Surg Oncol 2013; 20: 572-579.
17. Lencioni R, Crocetti L, Cioni R et al. Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study). Lancet Oncol 2008; 9: 621-628.